Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”

Leila T. Tchelebi; Karyn Goodman

doi:10.1016/j.radonc.2020.07.011

Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	e17
Journal	Radiotherapy and Oncology
Volume	154
DOIs	https://doi.org/10.1016/j.radonc.2020.07.011
State	Published - Jan 2021

Access to Document

10.1016/j.radonc.2020.07.011

Cite this

@article{af81d2738b914e91bac109efa9adda75,

title = "Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”",

author = "Tchelebi, {Leila T.} and Karyn Goodman",

year = "2021",

month = jan,

doi = "10.1016/j.radonc.2020.07.011",

language = "English",

volume = "154",

pages = "e17",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond”

AU - Tchelebi, Leila T.

AU - Goodman, Karyn

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85089107174&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2020.07.011

DO - 10.1016/j.radonc.2020.07.011

M3 - Letter

C2 - 32673775

AN - SCOPUS:85089107174

SN - 0167-8140

VL - 154

SP - e17

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

ER -